- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HCV Infection in New Zealand
Total 6861 results
-
Gilead SciencesCompletedHIV-1 Infection | HCV InfectionUnited States, Puerto Rico
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BNew Zealand
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
University of Auckland, New ZealandCompleted
-
Geneos TherapeuticsActive, not recruitingHCCUnited States, New Zealand
-
CytoDyn, Inc.CompletedHIV Infections | HIV -1 InfectionUnited States
-
Gilead SciencesCompletedChronic HBV InfectionUnited States, New Zealand
-
PDS Biotechnology Corp.CompletedHigh-risk HPV Infection and Biopsy-proven CIN1United States
-
Valneva Austria GmbHCompleted
-
Nina BhardwajNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsCompletedHIV-1 Infected Adults With Chronic HIV-1 InfectionUnited States
-
Monash UniversityThe AlfredRecruitingSurgical Site InfectionAustralia, New Zealand
-
Gilead SciencesCompleted
-
Kirby InstituteGilead Sciences; The University of New South WalesCompleted
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)CompletedHepatitis C | HIV | Co-InfectionUnited States
-
Rockefeller UniversityCompletedHIV Infection | Healthy Volunteers | HIV-1 InfectionUnited States
-
BLIS Technologies LimitedRecruitingMicrobial ColonizationNew Zealand
-
BLIS Technologies LimitedRecruiting
-
BLIS Technologies LimitedRecruiting
-
Syneos HealthUS Specialty Formulations, LLCCompletedSARS-CoV-2 (COVID-19)New Zealand
-
BLIS Technologies LimitedNot yet recruitingMicrobial ColonizationNew Zealand
-
BLIS Technologies LimitedNot yet recruiting
-
John HaleRecruiting
-
John HaleRecruiting
-
BLIS Technologies LimitedRecruiting
-
BLIS Technologies LimitedActive, not recruiting
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Gilead SciencesCompletedChronic Genotype 1a or 1b HCV InfectionUnited States, Canada, Puerto Rico
-
Icahn School of Medicine at Mount SinaiGilead SciencesCompletedHepatitis C InfectionUnited States
-
Janssen Research & Development, LLCCompletedHepatitis B, ChronicTaiwan, Poland, Japan, New Zealand
-
Kirby InstituteCompletedHepatitis CAustralia, United States, United Kingdom, New Zealand, Switzerland, Canada, Germany, Netherlands
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
Mylan Inc.Theravance BiopharmaCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
Myrexis Inc.CompletedHIV InfectionsAustralia
-
Gilead SciencesCompletedHCV InfectionUnited States
-
Hoffmann-La RocheTerminatedHepatitis B Virus InfectionUnited Kingdom, Hong Kong, Korea, Republic of, Taiwan, Poland, Bulgaria, New Zealand
-
New York UniversityNYU Langone HealthUnknownHIV-infection/AIDSUnited States
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV Infections | HIV SeronegativityUnited States, Puerto Rico
-
Rockefeller UniversityCompleted
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
Assembly BiosciencesCompletedChronic Hepatitis BSingapore, Hong Kong, Bulgaria, Moldova, Republic of, New Zealand, Romania
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand